We are monitoring the impact of COVID-19 on Artificial Skin Market Get in touch with us for detailed analysis Know More
Pulished Date October, 2021
ID: 12353
Share on
Share on

Global Artificial Skin Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Product Type, Replacement Area, Material, Application, End User & Region – Industry Forecast (2021 to 2026)

Pulished: October, 2021
ID: 12353
Pages: 190

Global Artificial Skin Market Size (2021 to 2026)

During the forecast period, the global artificial skin market size is predicted to grow at a CAGR of 6.4%

Artificial Skin is a synthetic substitute for human skin that can stimulate skin regeneration, dramatically improving the treatment of severe burns and injuries. The epidermis and dermis are the two layers of the skin, the human body's largest organ. Severe burns and wounds expose the body to infection and slow the healing process. Artificial skin aids in overcoming these barriers and speeds wound and burn to heal. Epicel, alloderm, and integra are three types of permanent artificial skin currently on the market. Epicel, also known as a cultivated epithelial autograft, is a type of epithelial autograft. Before being utilized as a graft, it is created from the patient's skin and cultivated for two to three weeks. In the case of deep wounds, alloderm is used to repair injured soft tissue. It isn't suitable for huge surfaces. Integra is a long-lasting synthetic skin substitute that encourages cell proliferation and aids in creating red blood cells.

Impact of COVID-19 on the global artificial skin market:

The COVID-19 pandemic is causing havoc around the planet. COVID-19 causes pneumonia, severe and acute respiratory difficulties, multiple organ failure, and death in the most severe cases. COVID-19 is more common in the elderly population. During the pandemic, the global artificial skin market grew at a slow pace. Governments in developing countries are investing heavily in modernizing healthcare infrastructure in their countries, intending to increase access to healthcare services. The need for artificial skin is projected to rise as a result of this.


Y-O-Y growth in the incidence of acute and chronic wounds is one of the significant factors driving the global artificial skin market.

As people become more aware of the various skin treatment choices, artificial skin is becoming more popular. Because artificial skin lacks immunogenic cells such as dendritic cells, auto rejection does not occur. The artificial skin market has grown significantly as the incidence of vehicle accidents, burns, and trauma-related incidents have increased. Increased incidence of burn injuries, rise in prevalence of chronic & acute wounds such as diabetic foot ulcers, the surge in R&D efforts for the development of new products, technological advancements such as sprays for treating burn injuries using the patient's cells for rapid recovery, and increase in health care expenditure in developed and developing countries are expected to drive the global artificial skin market.

Chronic wounds, such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers, are challenging to cure and costly to treat, putting a significant financial strain on healthcare systems. Chronic wounds are being formed due to an increase in the adoption of sedentary lifestyles, unhealthy eating habits, and the aggravation of chronic diseases such as obesity and diabetes. As a result of the rising number of diabetic and obese patients, the demand for quick wound healing has expanded dramatically. Over the forecast period, these factors are expected to boost demand for regenerating artificial skin.

The product's launch in Japan is expected to be a profitable opportunity for AVITA Medical, as the number of patients suffering from chronic wounds and decubitus ulcers in Japan has increased in recent years. Manufacturers are seeking ways to produce new products by investing in research and development regularly. Due to growing competition, the profit margins of established suppliers are decreasing as new vendors enter the market. To maintain their market positions, incumbent vendors are being pushed to develop new goods by increasing their R&D spending.


During the forecast period, the global artificial skin market is expected to be hampered by high costs associated with artificial skin implants, strict restrictions regarding the launch of new products, and limited awareness in low-income economies. In addition, there is a shortage of healthcare infrastructure and access to medical services in low and middle-income countries. Therefore, over the forecast period, it is expected to challenge market expansion.




Market Size Available

2020 to 2026

Base Year


Forecast Period

2021 to 2026

Segments Covered

By Product Type, Replacement Area, Material, Application, End-User & Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa


This research report on the global artificial skin market has been segmented and sub-segmented based on product type, replacement area, material, application, end-user & region.

Artificial Skin Market - By Product Type:

  • Permanent
  • Temporary
  • Composite

Artificial Skin Market - By Replacement area:

  • Dermal
  • Epidermal
  • Composed

Artificial Skin Market - By Material:

  • Natural
  • Synthetic
  • Both

Artificial Skin Market - By Application:

  • Acute wounds
  • Chronic wounds
  • Others

The chronic wounds segment had a significant share in the global artificial skin market in 2020 and are likely to grow during the forecast period. Diabetic foot ulcers, venous leg ulcers, and pressure ulcers are instances of chronic wounds. Chronic wounds have become more common as the worldwide geriatric population has grown, as has the prevalence of diabetes and obesity. Diabetes puts people at a higher risk of developing chronic wounds and infections. Nearly 40 to 60 million persons with diabetes worldwide suffer from diabetic foot and lower limb problems. As a result, the prevalence of chronic wounds is projected to be a significant factor in the artificial skin market's growth over the forecast period.

Artificial Skin Market - By End User:

  • Hospitals
  • Burn care Centers
  • Others

The expansion in the number of hospitals around the world and the easy availability of skin grafting facilities in hospitals can be attributed to the growth of the hospitals segment. Another factor boosting the global artificial skin market is the increased use of artificial skin by health care professionals to prevent infections in patients.

On the other hand, the burn care centers segment is expected to grow at a promising CAGR during the forecast period.

Artificial Skin Market – By Region:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Geographically, North America is expected to dominate the worldwide artificial skin market during the forecast period. This is due to a favorable regulatory environment and an increase in burn injuries, both of which have increased demand for permanent artificial skin for effective burn therapy. Manufacturers are seeking ways to produce new products by investing in research and development regularly. By the American Burn Association, nearly 40,000 patients were hospitalized in the United States for burn injuries between 2017 and 2018. Other major national organizations have produced similar studies on burn injuries. According to the Centers for Disease Control and Prevention, over 10,000 people in the United States die each year from diseases induced by burn injuries. To support market growth, more activities to raise awareness of skin and tissue donation are being implemented. Donate Life America and other organizations are undertaking an increasing number of awareness programs to raise awareness of skin illnesses that necessitate replacement operations and the necessity for skin donation. Donate Life America is a non-profit organization dedicated to promoting organ, eye, and tissue donation.

Due to an increase in research and development efforts, increased government initiatives for improving health care, and a surge in key players' focus on developing or reinforcing presence in the region, the market in the Asia Pacific is expected to grow at a quick rate during the forecast period.


AVITA Medical, Eucare Pharmaceuticals (P) Ltd., MiMedx, Aroa Biosurgery Limited, Integra LifeSciences, Mallinckrodt Pharmaceuticals, Medskin Suwelack, Misonix, and Organogenesis, Inc. are a few of the notable companies operating in the global artificial skin market and profiled in this report.


  • AVITA Medical and COSMOTEC, a subsidiary of M3 Group Company, partnered on March 4, 2019, to sell and distribute RECELL in Japan, intended to treat wounds caused by burns and other injuries.
  • 3M announced the acquisition of Acelity Inc. in October 2019 and its KCI subsidiaries, which is  a global medical technology firm focused on enhanced wound management.
  1. Introduction                                                          
    1. Market Definition                                               
    2. Scope of the report                                            
    3. Study Assumptions
    4. Base Currency, Base Year and Forecast Periods
  2. Research Methodology
    1. Analysis Design
    2. Research Phases
      1. Secondary Research
      2. Primary Research
      3. Data Modelling
      4. Expert Validation
    3. Study Timeline
  3. Report Overview
    1. Executive Summary
    2. Key Inferences
  4. Market Dynamics
    1. Impact Analysis
      1. Drivers
      2. Restraints
      3. Opportunities
    2. Regulatory Environment
    3. Technology Timeline & Recent Trends
  5. Competitor Benchmarking Analysis
    1. Key Player Benchmarking
      1. Market share analysis
      2. Products/Service
      3. Regional Presence
    2. Mergers & Acquisition Landscape
    3. Joint Ventures & Collaborations
  6. Market Segmentation
    1. Artificial Skin Market, By Product Type
      1. Permanent
      2. Temporary
      3. Composite
      4. Market Size Estimations & Forecasts (2021-2026)
      5. Y-o-Y Growth Rate Analysis
      6. Market Attractiveness Index
    2. Artificial Skin Market, By Replacement Area
      1. Dermal
      2. Epidermal
      3. Composed
      4. Market Size Estimations & Forecasts (2021-2026)
      5. Y-o-Y Growth Rate Analysis
      6. Market Attractiveness Index
    3. Artificial Skin Market, By Material
      1. Natural
      2. Synthetic
      3. Both
      4. Market Size Estimations & Forecasts (2021-2026)
      5. Y-o-Y Growth Rate Analysis
      6. Market Attractiveness Index
    4. Artificial Skin Market, By Application
      1. Acute wounds
      2. Chronic wounds
      3. Others
      4. Market Size Estimations & Forecasts (2021-2026)
      5. Y-o-Y Growth Rate Analysis
      6. Market Attractiveness Index
    5. Artificial Skin Market, By End-User
      1. Hospitals
      2. Burn care Centers
      3. Others
      4. Market Size Estimations & Forecasts (2021-2026)
      5. Y-o-Y Growth Rate Analysis
      6. Market Attractiveness Index
  7. Geographical Landscape
    1. Global Artificial Skin Market, by Region
    2. North America - Market Analysis (2021 to 2026)
      1. By Country
        1. USA
        2. Canada
    3. Europe                                                   
      1. By Country
        1. UK
        2. France
        3. Germany
        4. Spain
        5. Italy
        6. Rest of Europe
    4. Asia Pacific                                             
      1. By Country
        1. China                  
        2. India
        3. Japan                  
        4. South Korea
        5. Southeast Asia
        6. Australia & NZ
        7. Rest of Asia- Pacific
    5. Latin America
      1. By Country
        1. Brazil
        2. Argentina
        3. Mexico                
        4. Rest of Latin America
    6. The Middle East and Africa
      1. By Country
        1. Middle East
        2. Africa
  8. Key Player Analysis
    1. AVITA Medical
      1. Business Description
      2. Products/Service
      3. Financials                             
      4. SWOT Analysis
      5. Recent Developments
      6. Analyst Overview
    2. Eucare Pharmaceuticals (P) Ltd.
    3. MiMedx
    4. Aroa Biosurgery Limited
    5. Integra LifeSciences
    6. Mallinckrodt Pharmaceuticals
    7. Medskin Suwelack
    8. Misonix
    9. Organogenesis, Inc.
  9. Market Outlook & Investment Opportunities
  10. Appendix                                               
    1. List of Tables
    2. List of Figures
  • Global and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
  • Segment-level analysis in terms of product type, replacement area, material, application, end user along with market size forecasts and estimations to detect key areas of industry growth in detail.
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development.
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment.
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies.
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions.
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.

Artificial Skin Market

Please wait. . . . Your request is being processed

Related Reports


$ 1234 4250

Click for Request Sample